A new study shows that routine hospital blood tests could help predict spinal cord injury severity and survival chances.

NRXBF READ THE FULL NRXBF RESEARCH REPORT NurExone (OTC:NRXBF) is developing a product known as ExoPTEN that is designed to ...

A blood test could give spinal injury patients their chance of full or partial recovery The test depends in part on spinal cord DNA found in the bloodstream More severe injuries release higher levels ...

Spinal muscular atrophy (SMA) can cause weakness, difficulty controlling movements, and difficulty swallowing and breathing. It can be carried in certain genes. Spinal muscular atrophy (SMA) is a ...

A clinical trial of NVG-291 peptide drug demonstrates promising results for spinal cord injury patients, with participant ...

Nevro yesterday announced that the FDA has granted approval for a study evaluating its high-frequency spinal cord stimulation system for the treatment of chronic pain. The device company’s Senza ...

From breaking news to special features, we're on it! Join the NonStop Local Chord group and always be in the know. THURSDAY, April 3, 2025 (HealthDay News) -- An experimental blood test might be able ...

THURSDAY, April 3, 2025 (HealthDay News) -- An experimental blood test might be able to help doctors predict whether someone will recover their mobility following a spinal cord injury. The test looks ...